Imagion Biosystems Limited (IBXXF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 5.81 Million AUD | 3571.81% |
| 2022 | 158.26 Thousand AUD | 101.19% |
| 2021 | -13.34 Million AUD | -6.45% |
| 2020 | -12.53 Million AUD | -396.63% |
| 2019 | -2.52 Million AUD | 41.45% |
| 2018 | -4.31 Million AUD | 36.51% |
| 2017 | -6.79 Million AUD | -437.27% |
| 2016 | 2.01 Million AUD | -77.88% |
| 2015 | 9.1 Million AUD | 126.13% |
| 2014 | 4.02 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 FY | 5.81 Million AUD | 3571.81% |
| 2023 Q3 | 4.71 Million AUD | 14.59% |
| 2023 Q4 | 5.81 Million AUD | 23.23% |
| 2023 Q1 | 4.11 Million AUD | 2500.19% |
| 2023 Q2 | 4.11 Million AUD | 0.0% |
| 2022 Q2 | -4.53 Million AUD | 0.0% |
| 2022 Q4 | 158.26 Thousand AUD | 117.93% |
| 2022 FY | 158.26 Thousand AUD | 101.19% |
| 2022 Q1 | -4.53 Million AUD | 66.13% |
| 2022 Q3 | -882.78 Thousand AUD | 80.52% |
| 2021 Q1 | -13.89 Million AUD | -10.77% |
| 2021 FY | -13.34 Million AUD | -6.45% |
| 2021 Q4 | -13.37 Million AUD | -0.12% |
| 2021 Q3 | -13.36 Million AUD | 3.8% |
| 2021 Q2 | -13.89 Million AUD | 0.0% |
| 2020 FY | -12.53 Million AUD | -396.63% |
| 2020 Q1 | -3.87 Million AUD | -53.49% |
| 2020 Q2 | -3.87 Million AUD | 0.0% |
| 2020 Q4 | -12.53 Million AUD | 2.78% |
| 2020 Q3 | -12.89 Million AUD | -232.81% |
| 2019 Q1 | -1.12 Million AUD | 73.99% |
| 2019 Q3 | -2.78 Million AUD | -148.42% |
| 2019 Q4 | -2.52 Million AUD | 9.39% |
| 2019 FY | -2.52 Million AUD | 41.45% |
| 2019 Q2 | -1.12 Million AUD | 0.0% |
| 2018 Q4 | -4.31 Million AUD | 0.83% |
| 2018 Q2 | -3.55 Million AUD | 0.0% |
| 2018 Q1 | -3.55 Million AUD | 47.67% |
| 2018 FY | -4.31 Million AUD | 36.51% |
| 2018 Q3 | -4.34 Million AUD | -22.34% |
| 2017 Q2 | -12.27 Million AUD | 0.0% |
| 2017 Q1 | -12.27 Million AUD | 0.0% |
| 2017 FY | -6.79 Million AUD | -437.27% |
| 2017 Q4 | -6.79 Million AUD | 0.45% |
| 2017 Q3 | -6.82 Million AUD | 44.41% |
| 2016 FY | 2.01 Million AUD | -77.88% |
| 2015 FY | 9.1 Million AUD | 126.13% |
| 2014 FY | 4.02 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.2 Million USD | -163.43% |
| Arrayit Corporation | 1.05 Million USD | -450.528% |
| Atlantic International Corp. | 236.49 Thousand USD | -2357.235% |
| Biocept, Inc. | -788 Thousand USD | 837.47% |
| Bioqual, Inc. | -12 Million USD | 148.399% |
| CardioGenics Holdings Inc | 22.73 Thousand USD | -25456.366% |
| DermTech, Inc. | 17.65 Million USD | 67.081% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | -572.49 Million USD | 101.015% |
| HTG Molecular Diagnostics, Inc. | -7.37 Million USD | 178.776% |
| iMD Companies, Inc. | 1.11 Million USD | -420.763% |
| IDenta Corp. | 524.85 Thousand USD | -1007.219% |
| Interpace Biosciences, Inc. | 7.69 Million USD | 24.47% |
| Integrative Health Technologies, Inc. | -26.95 Thousand USD | 21661.524% |
| InVitro International | -313.14 Thousand USD | 1955.791% |
| Lumos Diagnostics Holdings Limited | 1.56 Million USD | -271.11% |
| Many Bright Ideas Technologies Inc. | -713.00 USD | 815143.759% |
| Medical Imaging Corp. | 3.79 Million USD | -53.294% |
| NovelStem International Corp. | 3.52 Million USD | -65.021% |
| Optigenex Inc. | 8.93 Million USD | 34.953% |
| PharmChem, Inc. | -1.49 Million USD | 488.866% |
| Proteome Sciences plc | 14.57 Million USD | 60.124% |
| Response Genetics, Inc | -13.08 Million USD | 144.408% |
| Rennova Health, Inc. | 14.82 Million USD | 60.814% |
| RushNet, Inc. | 4.8 Million USD | -21.047% |
| ScreenPro Security Inc. | 135.58 Thousand USD | -4185.939% |
| Stella Diagnostics Inc. | 6.19 Million USD | 6.165% |
| StageZero Life Sciences Ltd. | 1.78 Million USD | -225.671% |
| Todos Medical Ltd. | 38.31 Million USD | 84.833% |